{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:12:22Z","timestamp":1785528742146,"version":"3.56.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institute for Health and Care Research, Research for Patient Benefit","award":["PB-PG-1217-20017"],"award-info":[{"award-number":["PB-PG-1217-20017"]}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>GCA is systemic vasculitis manifesting as cranial, ocular or large vessel vasculitis. A prior qualitative study developed 40 candidate items to assess the impact of GCA on health-related quality of life (HRQoL). This study aimed to determine final scale structure and measurement properties of the GCA patient reported outcome (GCA-PRO) measure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cross-sectional study included UK patients with clinician-confirmed GCA. They completed 40 candidate items for the GCA-PRO at times 1 and 2 (3\u2009days apart), EQ-5D-5L, ICECAP-A, CAT-PROM5 and self-report of disease activity. Rasch and exploratory factor analyses informed item reduction and established structural validity, reliability and unidimensionality of the final GCA-PRO. Evidence of validity was also established with hypothesis testing (GCA-PRO vs other PRO scores, and between participants with \u2018active disease\u2019 vs those \u2018in remission\u2019) and test\u2013retest reliability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study population consisted of 428 patients: mean (s.d.) age 74.2 (7.2), 285 (67%) female; 327 (76%) cranial GCA, 114 (26.6%) large vessel vasculitis and 142 (33.2%) ocular involvement. Rasch analysis eliminated 10 candidate GCA items and informed restructuring of response categories into four-point Likert scales. Factor analysis confirmed four domains: acute symptoms (eight items), activities of daily living (seven items), psychological (seven items) and participation (eight items). The overall scale had adequate Rasch model fit (\u03c72\u2009=\u200925.219, degrees of freedom\u2009=\u200924, P\u2009=\u20090.394). Convergent validity with EQ5D-5L, ICECAP-A and Cat-PROM5 was confirmed through hypothesis testing. Internal consistency and test\u2013retest reliability were excellent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The final GCA-PRO is a 30-item, four-domain scale with robust evidence of validity and reliability in measuring HRQoL in people with GCA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead201","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:33:55Z","timestamp":1683293635000},"page":"181-189","source":"Crossref","is-referenced-by-count":8,"title":["Validation of a patient-reported outcome measure for giant cell arteritis"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-3173","authenticated-orcid":false,"given":"Mwidimi","family":"Ndosi","sequence":"first","affiliation":[{"name":"School of Health and Social Wellbeing, University of the West of England , Bristol, UK"},{"name":"Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Almeida","sequence":"additional","affiliation":[{"name":"School of Health and Social Wellbeing, University of the West of England , Bristol, UK"},{"name":"Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-1333","authenticated-orcid":false,"given":"Jill","family":"Dawson","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health (HSRU), University of Oxford , Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-8607","authenticated-orcid":false,"given":"Emma","family":"Dures","sequence":"additional","affiliation":[{"name":"School of Health and Social Wellbeing, University of the West of England , Bristol, UK"},{"name":"Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-5225","authenticated-orcid":false,"given":"Rosemary","family":"Greenwood","sequence":"additional","affiliation":[{"name":"NIHR Research Design Service South West, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Bromhead","sequence":"additional","affiliation":[{"name":"School of Health and Social Wellbeing, University of the West of England , Bristol, UK"},{"name":"Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guly","sequence":"additional","affiliation":[{"name":"Bristol Eye Hospital, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Stern","sequence":"additional","affiliation":[{"name":"School of Health and Social Wellbeing, University of the West of England , Bristol, UK"},{"name":"Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8289-4922","authenticated-orcid":false,"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[{"name":"Discipline of Medicine, The University of Adelaide , Adelaide, Australia"},{"name":"Rheumatology Unit, Royal Adelaide Hospital , Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-5873","authenticated-orcid":false,"given":"Sarah","family":"Mackie","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds, UK"},{"name":"Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-5978","authenticated-orcid":false,"given":"Joanna C","family":"Robson","sequence":"additional","affiliation":[{"name":"School of Health and Social Wellbeing, University of the West of England , Bristol, UK"},{"name":"Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"2024010500305071100_kead201-B1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.22429","article-title":"Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities","volume":"67","author":"Petri","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024010500305071100_kead201-B2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol"},{"key":"2024010500305071100_kead201-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024010500305071100_kead201-B4","doi-asserted-by":"crossref","first-page":"ii63","DOI":"10.1093\/rheumatology\/kex428","article-title":"Ophthalmic manifestations of giant cell arteritis","volume":"57","author":"Vodopivec","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2024010500305071100_kead201-B5","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"2024010500305071100_kead201-B6","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2024010500305071100_kead201-B7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.semarthrit.2020.06.019","article-title":"The patient's perspective of the adverse effects of glucocorticoid use: a systematic review of quantitative and qualitative studies. From an OMERACT working group","volume":"50","author":"Cheah","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2024010500305071100_kead201-B8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3899\/jrheum.180429","article-title":"Efficacy of methotrexate in real-world management of giant cell arteritis: a case-control study","volume":"46","author":"Koster","year":"2019","journal-title":"J Rheumatol"},{"key":"2024010500305071100_kead201-B9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2024010500305071100_kead201-B10","doi-asserted-by":"crossref","first-page":"c186","DOI":"10.1136\/bmj.c186","article-title":"The routine use of patient reported outcome measures in healthcare settings","volume":"340","author":"Dawson","year":"2010","journal-title":"BMJ"},{"key":"2024010500305071100_kead201-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2140","article-title":"Evaluating patient-based outcome measures for use in clinical trials","volume":"2","author":"Fitzpatrick","year":"1998","journal-title":"Health Technol Assess"},{"key":"2024010500305071100_kead201-B12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2024010500305071100_kead201-B13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"key":"2024010500305071100_kead201-B14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"2024010500305071100_kead201-B15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2869.2006.00544.x","article-title":"Development of the sleep quality scale","volume":"15","author":"Yi","year":"2006","journal-title":"J Sleep Res"},{"key":"2024010500305071100_kead201-B16","first-page":"2250","article-title":"Incorporating the patient perspective into outcome assessment in rheumatoid arthritis\u2013progress at OMERACT 7","volume":"32","author":"Kirwan","year":"2005","journal-title":"J Rheumatol"},{"key":"2024010500305071100_kead201-B17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3899\/jrheum.141144","article-title":"Update on outcome measure development for large vessel vasculitis: report from OMERACT 12","volume":"42","author":"Aydin","year":"2015","journal-title":"J Rheumatol"},{"key":"2024010500305071100_kead201-B18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00041327-200112000-00008","article-title":"Visual function and quality of life among patients with giant cell (temporal) arteritis","volume":"21","author":"Kupersmith","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"2024010500305071100_kead201-B19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"2024010500305071100_kead201-B20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2288-10-22","article-title":"The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content","volume":"10","author":"Mokkink","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"2024010500305071100_kead201-B21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/PPA.S104259","article-title":"Patient involvement in clinical research: why, when, and how","volume":"10","author":"Sacrist\u00e1n","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"2024010500305071100_kead201-B22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/acr.20276","article-title":"Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective","volume":"62","author":"Herlyn","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024010500305071100_kead201-B23","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1093\/rheumatology\/keab076","article-title":"Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure","volume":"60","author":"Robson","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2024010500305071100_kead201-B24","author":"UKIVAS","year":"2023"},{"key":"2024010500305071100_kead201-B25","author":"Leeds Institute for Data Analytics","year":"2023"},{"key":"2024010500305071100_kead201-B26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11136-011-9927-2","article-title":"Development of a self-report measure of capability wellbeing for adults: the ICECAP-A","volume":"21","author":"Al-Janabi","year":"2012","journal-title":"Qual Life Res"},{"key":"2024010500305071100_kead201-B27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/eye.2018.1","article-title":"Cat-PROM5: a brief psychometrically robust self-report questionnaire instrument for cataract surgery","volume":"32","author":"Sparrow","year":"2018","journal-title":"Eye (Lond)"},{"key":"2024010500305071100_kead201-B28","first-page":"2526","article-title":"Rasch rating scale item estimates using maximum likelihood approach: effects of sample size on the accuracy and bias of the estimates","volume":"29","author":"Azizan","year":"2020","journal-title":"Int J Adv Sci Technol"},{"key":"2024010500305071100_kead201-B29","first-page":"328","article-title":"Sample size and item calibration stability","volume":"7","author":"Linacre","year":"1994","journal-title":"Rasch Measur Trans"},{"key":"2024010500305071100_kead201-B30","doi-asserted-by":"crossref","DOI":"10.4324\/9781410600127","volume-title":"Applying the Rasch model: fundamental measurement in the human sciences","author":"Bond","year":"2001"},{"key":"2024010500305071100_kead201-B31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF02296400","article-title":"Criterion-related construct-validity","volume":"54","author":"Rosenbaum","year":"1989","journal-title":"Psychometrika"},{"key":"2024010500305071100_kead201-B32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02293746","article-title":"Sufficient statistics and latent trait models","volume":"42","author":"Anderen","year":"1977","journal-title":"Psychometrika"},{"key":"2024010500305071100_kead201-B33","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.23108","article-title":"The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper","volume":"57","author":"Tennant","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2024010500305071100_kead201-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/014466506X96931","article-title":"An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS)","volume":"46","author":"Pallant","year":"2007","journal-title":"Br J Clin Psychol"},{"key":"2024010500305071100_kead201-B35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1745-3992.2000.tb00041.x","article-title":"Incorporating the testlet concept in test score analyses","volume":"19","author":"Guemin","year":"2000","journal-title":"Educ Measur Issues Pract"},{"key":"2024010500305071100_kead201-B36","first-page":"205","article-title":"Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals","volume":"3","author":"Smith","year":"2002","journal-title":"J Appl Measur"},{"key":"2024010500305071100_kead201-B37","first-page":"153","article-title":"Rasch fit statistics as a test of the invariance of item parameter estimates","volume":"4","author":"Smith","year":"2003","journal-title":"J Appl Meas"},{"key":"2024010500305071100_kead201-B38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3111\/13696990701557048","article-title":"Methodological aspects of differential item functioning in the Rasch model","volume":"10","author":"Brodersen","year":"2007","journal-title":"J Med Econ"},{"key":"2024010500305071100_kead201-B39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"2024010500305071100_kead201-B40","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11136-014-0632-9","article-title":"Getting serious about test-retest reliability: a critique of retest research and some recommendations","volume":"23","author":"Polit","year":"2014","journal-title":"Qual Life Res"},{"key":"2024010500305071100_kead201-B41","first-page":"857","article-title":"Observations are always ordinal \u2013 measurements, however, must be interval","volume":"70","author":"Wright","year":"1989","journal-title":"Arch Phys Med Rehabil"},{"key":"2024010500305071100_kead201-B42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual Life Res"},{"key":"2024010500305071100_kead201-B43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kez251","article-title":"Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data","volume":"59","author":"Mahr","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2024010500305071100_kead201-B44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","article-title":"Understanding the minimum clinically important difference: a review of concepts and methods","volume":"7","author":"Copay","year":"2007","journal-title":"Spine J"},{"key":"2024010500305071100_kead201-B45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"2024010500305071100_kead201-B46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/PROM.S156291","article-title":"PROMs data: can it be used to make decisions for individual patients? A narrative review","volume":"10","author":"Field","year":"2019","journal-title":"Patient Relat Outcome Meas"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead201\/50465501\/kead201.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/1\/181\/55030443\/kead201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/1\/181\/55030443\/kead201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:31:21Z","timestamp":1704414681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/1\/181\/7152987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,5]]},"published-print":{"date-parts":[[2024,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead201","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,5,5]]}}}